Skip to main content

Roundup's Primary Glyphosate Safe To Use Assures EPA

Roundup's Primary Glyphosate Safe To Use Assures EPA

Roundup's Primary Glyphosate Safe To Use Assures EPA

Introduction

EPA recently announced over the usage of Glyphosate that it doesn't cause cancer.

According to the review, glyphosate is the most-used herbicide in the U.S and meets the standard in the Federal Insecticide, Fungicide, and Rodenticide Act. It is one of the primary ingredients of Roundup. The California Office of Environmental Health Hazard Assessment had included glyphosate on a list of carcinogenic chemicals based on the World Health Organization’s  International Agency for Research(IARC). EPA stated, it probably doesn't cause cancer and can be used with some fine adjustments; also, its testing methods are more superior than IARC's.

The first trial against Monsanto over Roundup was held last summer in state court in San Francisco, which ruled in favor of plaintiffs with $78 million. The second ended last month in federal court with an $80 million verdict, including $75 million in punitive damages. The third trial is ongoing.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!